Takeda A, Shigematsu N, Suzuki S, Fujii M, Kawata T, Kawaguchi O, Uno T, Takano H, Kubo A, Ito H
Department of Radiology, School of Medicine, Keio University, Tokyo, Japan.
Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):599-605. doi: 10.1016/s0360-3016(99)00057-7.
Radiation-induced cataract, once a notorious ocular complication of radiation therapy, is no longer considered a severe complication, because visual acuity can be restored by surgical treatment without significant complications. Late retinal complications of retinopathy and glaucoma, for which there is no effective method of treatment, have become serious complications of radiotherapy of the head and neck. We retrospectively investigated the risk of late retinal complications of radiotherapy for nasal and paranasal malignancies according to the radiation dose and area of the retina irradiated.
Between October 1982 and May 1996, 43 eyes of 25 patients were exposed to fractionated external-beam irradiation for treatment of advanced nasal and paranasal cancer. None of the patients had tumor invasion into the eyes. The patients were followed ophthalmologically for a minimum of 2 years (range 2.0-11, mean 4.5, median 3.3). The radiation dose and area of the retina irradiated were estimated from the dose distribution figures calculated using the portal films and CT scan.
Major late adverse effects of radiotherapy were observed in the retina in 9 of 43 eyes (in 8/25 patients). Radiation retinopathy was observed in 7 eyes, and the cumulative incidence was 25%. The median interval before the onset of symptoms attributable to retinopathy was 32 months (range 16-60). Neovascular glaucoma developed in 3 of the 43 eyes, with a cumulative incidence of 7%. The median period to the onset of symptoms attributable to glaucoma was 22 months (range 16-26). Obstruction of the central retinal artery was observed in 1 eye. The irradiation doses to the retinas that developed late complications ranged between 54-75 Gy (mean 61, median 61). No patients who received less than 50 Gy developed retinal complications. The retina in 21 eyes was exposed to a dose of 50 Gy or more. In 13 of the 21 eyes, 60% or more of the retina was irradiated, and 8 of the eyes (62%) in this group (> or = 50 Gy, > or = 60%) developed severe retinal complications, whereas such complications only developed in 1 of the 8 eyes (13%) in the other group (> or = 50 Gy, > or = 60%). The results suggest that the radiation dose and area irradiated are the most important factors in the development of severe complications.
Radiation-induced retinopathy and glaucoma are more serious late complications than cataracts, which are easily treated with surgery. We investigated the risk of late retinal complications of radiotherapy, and our findings suggested that the radiation dose and area irradiated are the most important factors in the development of severe complications. We recommend that the radiation dose and area of the retina irradiated be minimized in patients at risk of eye complications, and the patients should be closely followed by periodic ophthalmologic testing after treatment.
放射性白内障曾是放射治疗中一种声名狼藉的眼部并发症,如今已不再被视为严重并发症,因为通过手术治疗可恢复视力且无明显并发症。而视网膜病变和青光眼等晚期视网膜并发症尚无有效治疗方法,已成为头颈部放疗的严重并发症。我们根据辐射剂量和视网膜受照面积,回顾性研究了鼻腔及鼻窦恶性肿瘤放疗后发生晚期视网膜并发症的风险。
1982年10月至1996年5月,25例患者的43只眼接受了分次外照射治疗晚期鼻腔及鼻窦癌。所有患者均无肿瘤侵犯眼球。对患者进行了至少2年的眼科随访(范围2.0 - 11年,平均4.5年,中位数3.3年)。根据使用射野片和CT扫描计算出的剂量分布数据估算视网膜的辐射剂量和受照面积。
43只眼中有9只眼(25例患者中的8例)在视网膜观察到放疗的主要晚期不良反应。7只眼出现放射性视网膜病变,累积发生率为25%。视网膜病变相关症状出现前的中位间隔时间为32个月(范围16 - 60个月)。43只眼中有3只眼发生新生血管性青光眼,累积发生率为7%。青光眼相关症状出现的中位时间为22个月(范围16 - 26个月)。1只眼观察到视网膜中央动脉阻塞。发生晚期并发症的视网膜照射剂量在54 - 75 Gy之间(平均61 Gy,中位数61 Gy)。接受剂量低于50 Gy的患者均未发生视网膜并发症。21只眼的视网膜接受了50 Gy或更高剂量照射。在这21只眼中,13只眼的视网膜受照面积达到或超过60%,该组中有8只眼(62%)(≥50 Gy,≥60%)发生了严重视网膜并发症,而另一组8只眼(≥50 Gy,≥60%)中只有1只眼(13%)发生了此类并发症。结果表明,辐射剂量和受照面积是发生严重并发症的最重要因素。
放射性视网膜病变和青光眼是比白内障更严重的晚期并发症,白内障通过手术易于治疗。我们研究了放疗后晚期视网膜并发症的风险,研究结果表明辐射剂量和受照面积是发生严重并发症的最重要因素。我们建议,对于有眼部并发症风险的患者,应尽量减少视网膜的辐射剂量和受照面积,并且治疗后应通过定期眼科检查对患者进行密切随访。